Abstract | BACKGROUND: METHODS: I/R was created by clamping the right renal pedicle for 60 min after left nephrectomy. Balb/c mice were divided into four groups (n=15 in each group): sham operation ( Sham), vehicle treatment (Vehicle), EPO treatment (EPO), and asialoEPO treatment ( AsialoEPO). EPO and asialoEPO were given at a dose of 500 IU/kg 30 min before I/R. Plasma creatinine (Cr), survival, and the number of apoptotic cells were analyzed. Protein expression was analyzed by Western blotting. RESULTS: Plasma Cr level was not significantly different at 6 hr after I/R. At 24 hr after I/R, the Cr (mg/dL) levels in Sham, Vehicle, EPO, and asialoEPO were 0.13+/-0.01, 1.24+/-0.70, 0.24+/-0.08, and 0.25+/-0.13, respectively (P<0.05). The numbers of apoptotic cells in these groups were 0.1+/-0.1, 98.9+/-42.6, 3.3+/-0.7, and 2.9+/-1.6, respectively (P<0.05). Western blotting revealed that in kidney tissue of mice treated with EPO and asialoEPO, p38-MAPK and the proapoptotic molecule Bad was decreased, and the antiapoptotic molecules Bcl-xL and XIAP were increased. Survival rates at 7 days after I/R injury in the Sham, Vehicle, EPO, and AsialoEPO groups were 100%, 21.4%, 23.1%, and 53.8%, respectively (P=0.05). CONCLUSION: EPO and asialoEPO attenuated renal dysfunction caused by I/R in mouse kidney at the same level, but only asialoEPO improved survival.
|
Authors | Toshie Okada, Tokihiko Sawada, Keiichi Kubota |
Journal | Transplantation
(Transplantation)
Vol. 84
Issue 4
Pg. 504-10
(Aug 27 2007)
ISSN: 0041-1337 [Print] United States |
PMID | 17713435
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Asialoglycoproteins
- Bad protein, mouse
- Bcl2l1 protein, mouse
- X-Linked Inhibitor of Apoptosis Protein
- asialoerythropoietin
- bcl-Associated Death Protein
- bcl-X Protein
- Erythropoietin
- Creatinine
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Asialoglycoproteins
(therapeutic use)
- Creatinine
(blood)
- Disease Models, Animal
- Erythropoietin
(analogs & derivatives, therapeutic use)
- Female
- Kidney
(metabolism, pathology, physiopathology)
- Mice
- Mice, Inbred BALB C
- Random Allocation
- Reperfusion Injury
(metabolism, pathology, prevention & control)
- Survival Rate
- X-Linked Inhibitor of Apoptosis Protein
(metabolism)
- bcl-Associated Death Protein
(antagonists & inhibitors)
- bcl-X Protein
(metabolism)
- p38 Mitogen-Activated Protein Kinases
(antagonists & inhibitors)
|